UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 18, 2021
BIO-key International, Inc. (Exact name of registrant as specified in its charter) |
Delaware (State or other jurisdiction of incorporation) | 1-13463 (Commission File Number) | 41-1741861 (I.R.S. Employer Identification No.) |
3349 Highway 138, Building A, Suite E Wall, NJ 07719 (Address of principal executive offices) |
(732) 359-1100 (Registrant’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock | BKYI | Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
BIO-key International, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on Friday, June 18, 2021. All holders of record of the Company’s common stock outstanding as of the close of business on April 26, 2021 were entitled to vote at the Annual Meeting. At the Annual Meeting, stockholders approved the proposals set forth below. Each of the proposals is more fully described in the Company’s definitive proxy statement, which was filed with the Securities and Exchange Commission on May 4, 2021.
1. Proposal to elect the following nominees to serve as members of the Company’s board of directors for a one-year term: Michael W. DePasquale, Wong Kwok Fong (Kelvin), Thomas Gilley, Thomas E. Bush, III, Pieter Knook, Robert J. Michel, and Emmanuel Alia (Manny). Each of the nominees were elected and the final voting results were as follows:
Name | Votes For | Withheld | Broker Non-Votes |
Michael DePasquale | 1,308,942 | 489,263 | 2,395,727 |
Wong Kwok Fong (Kelvin) | 1,339,649 | 458,556 | 2,395,727 |
Thomas Gilley | 1,314,072 | 484,133 | 2,395,727 |
Thomas E. Bush, III | 1,336,089 | 462,116 | 2,395,727 |
Pieter Knook | 1,339,569 | 458,636 | 2,395,727 |
Robert J. Michel | 1,335,603 | 462,602 | 2,395,727 |
Emmanuel Alia (Manny) | 1,341,732 | 456,473 | 2,395,727 |
2. Proposal to adopt the BIO-key International, Inc. 2021 Employee Stock Purchase Plan. The proposal was approved and the final voting results were as follows:
Votes For | Votes Against | Abstentions | Broker Non-Votes |
1,268,931 | 519,087 | 10,187 | 2,395,727 |
3. Proposal to adopt an amendment to the BIO-key International, Inc. 2015 Equity Incentive Plan. The proposal was approved and the final voting results were as follows:
Votes For | Votes Against | Abstentions | Broker Non-Votes |
1,242,305 | 541,277 | 14,623 | 2,395,727 |
4. Proposal to ratify the selection of Rotenberg Meril Solomon Bertiger & Guttilla, P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2021. The proposal was approved and the final voting results were as follows:
Votes For | Votes Against | Abstentions | Broker Non-Votes |
3,493,645 | 680,625 | 19,662 | - |
5. Proposal to approve, on a non-binding and advisory basis, the compensation paid to the Company’s named executive officers. The proposal was approved and the final voting results were as follows:
Votes For | Votes Against | Abstentions | Broker Non-Votes |
1,224,534 | 533,740 | 19,931 | 2,395,727 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BIO-KEY INTERNATIONAL, INC. | |||
Date: June 21, 2021 | |||
By: | /s/ Cecilia C. Welch | ||
Cecilia C. Welch | |||
Chief Financial Officer | |||